SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine plus Rituximab (BR) in Patients With Treatment-Naive (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Kahl, BS (author)

Giannopoulos, K (author)

Jurczak, W (author)

show more...

Simkovic, M (author)

Shadman, M (author)

Osterborg, A (author)

Laurenti, L (author)

Walker, P (author)

Opat, S (author)

Chan, H (author)

Ciepluch, H (author)

Greil, R (author)

Tani, M (author)

Trneny, M (author)

Brander, DM (author)

Flinn, IW (author)

Grosicki, S (author)

Verner, E (author)

Brown, JR (author)

Ghia, P (author)

Li, J (author)

Tian, T (author)

Zhou, L (author)

Marimpietri, C (author)

Paik, JC (author)

Cohen, A (author)

Robak, T (author)

Hillmen, P (author)

Tam, CS (author)

show less...

2022

2022

English.

In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. - 2152-2650. ; 22, s. S269-S270

Related links:

http://kipublication...

• Conference paper (other academic/artistic)